(Q50619584)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

José Luis Rodríguez-Peralto

21 February 2020

author

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Jose A. Lopez-Martin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

María Teresa Agulló Ortuño

21 February 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

C Vanesa Díaz-García

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Alba Agudo-López

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Carlos Pérez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Elena Prieto-García

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Lara Iglesias

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Santiago Ponce

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Analia Rodríguez Garzotto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Hernán Cortés-Funes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

25 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

1199-1206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-014-2729-8

21 February 2020

exact match

0 references

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

European cancer mortality predictions for the year 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Protein-tyrosine phosphatases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Inside the human cancer tyrosine phosphatome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Dual-specificity phosphatases: critical regulators with diverse cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

DUSP6/MKP-3 inactivates ERK1/2 but fails to bind and inactivate ERK5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Dual-specificity MAP kinase phosphatases (MKPs) and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

A five-gene signature and clinical outcome in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Abrogation of DUSP6 by hypermethylation in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Dual-specificity phosphatase 6 (Dusp6), a negative regulator of FGF2/ERK1/2 signaling, enhances 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Gene expression from bronchoscopy obtained tumour samples as a predictor of outcome in advanced inoperable lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2729-8

Catalytic Activation of the Phosphatase MKP-3 by ERK2 Mitogen-Activated Protein Kinase

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25344212

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-014-2729-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344212%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference